Disc Medicine, Inc.
IRON
Rangering i aksjer
#4958
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a... Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Aksjekurs
$75.39
Sist synkronisert: 2026-10-22
Markedsverdi
$2.89B
Endring (1 dag)
-0.80%
Endring (1 år)
-9.92%
Land
US
Handel Disc Medicine, Inc. (IRON)
Kategori
Healthcare
Utbytteavkastning for Disc Medicine, Inc. (IRON)
Disc Medicine, Inc. (aksjesymbol: IRON) sin utbytteavkastning (TTM) per 2024-12-31 er: 0.00%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Disc Medicine, Inc. (IRON) fra 2020 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
| År | Utbytteavkastning | Endre |
|---|---|---|
| 2026 (TTM) | 0.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | 0.00% |
| 2020 | 0.00% | 0.00% |
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter
| Selskap | Utbytteavkastning | Land |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.07% |
AU
|
|
| 0.56% |
BE
|
|
| 0.00% |
NL
|
